您搜索了: eczema (丹麦语 - 英语)

eczema arthriticum
vulgar arthrophlysis

eczema in ichthyotico
eczéma in ichthyotico

forstyrrelser i eczema, urticaria hud og og kløen. subkutant væv
eczema, urticaria and itching.

eczema area and severity index) fra baseline til måned 3.
defined as the proportion of patients with at least 60% improvement in the measi (modified eczema area and severity index) between baseline and month 3.

er eczema area and severity index) fra baseline til måned 3.
au area and severity index) between baseline and month 3.

herpes virus infektioner (herpes simplex dermatitis [eczema herpeticum], herpes
herpes viral infections (herpes simplex dermatitis [eczema herpeticum], herpes simplex [cold sores], kaposi’ s varicelliform eruption)

forstyrrelser i eczema, urticaria hud og og kløen. subkutant væv forstrelser i hovedpine og nervesystemet svimmelhed.
stevens-johnson syndrome and toxic epidermal necrolysis.

denne præmie på 5 000 € blev vundet af pipa grierson fra new zealand for "fighting facial eczema".
the prize, worth € 5.000, was won by pipa grierson from new zealand for "fighting facial eczema".

(herpes simplex dermatitis [eczema herpeticum], herpes simplex [forkølelsessår], kaposi' s er
treatment with protopy may be associated with an increased risk of herpes viral infections (herpes simplex dermatitis [eczema herpeticum], herpes simplex [cold sores], kaposi’ s varicelliform lp

til dette formål blev der anvendt et score- system (det såkaldte modified eczema area and severity index), hvor alle symptomer på atopisk dermatitis tages i betragtning.
the main measure of effectiveness was the improvement in the eczema seen at the end of the study (3 or 12 weeks) using a scoring system (the modified eczema area and severity index) that looks at all the symptoms of atopic dermatitis.

den primære parameter var respons raten ved måned 3, defineret som delen af patientgruppen med mindst 60% forbedring i measi (modified eczema area and severity index) fra baseline til måned 3.
the primary endpoint was the response rate at month 3 defined as the proportion of patients with at least 60% improvement in the measi (modified eczema area and severity index) between baseline and month 3.